- HIV RNA < 400 copies/mL prior to study entry by any US laboratory that has a CLIA certification or its equivalent [HIV seropositive participants only] 10. On a qualifying antiretroviral therapy (ART) regimen for at least 14 weeks prior to entry/day0 [HIV seropositive participants only]